Conditional survival analysis of four treatment strategies for patients with stage I non‑small cell lung cancer

Liang,Yicheng; Fan,Xiaoxi; Bai,Yunpeng; Huang,Dejian; Yang,Chunlu

doi:10.3892/ol.2019.10413

Conditional survival analysis of four treatment strategies for patients with stage I non‑small cell lung cancer

Authors:
- Yicheng Liang
- Xiaoxi Fan
- Yunpeng Bai
- Dejian Huang
- Chunlu Yang
View Affiliations

Affiliations: Department of Thoracic Surgery, First Hospital of China Medical University, Shenyang, Liaoning 110001, P.R. China, Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110001, P.R. China
Published online on: May 30, 2019 https://doi.org/10.3892/ol.2019.10413
Pages: 1089-1098
Copyright: © Liang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Conditional survival (CS) is used to describe dynamic survival possibility, taking account of the change in the survival risk that occurs with longevity. The present study aimed to explore the CS of four treatment strategies for stage I non‑small cell lung cancer (NSCLC), staged according to the eighth edition of the American Joint Committee on Cancer/Union for International Cancer Control NSCLC staging system. Using the Surveillance, Epidemiology and End Results Program cohort obtained between 2004‑2014, the current study first extracted data for 27,116 patients with stage I NSCLC. The actuarial cancer‑specific survival rates (ACSs) and conditional cancer‑specific survival rates of four treatment strategies were then compared. ACS was assessed using the Kaplan‑Meier method and a log‑rank test. The 3‑year conditional cancer‑specific survival (CCS3) of patients who had already survived for n years was calculated as CCS3=ACS(n+3)/ACS(n). Cox regression and propensity‑score matching (PSM) was applied to adjust confounding factors. The 5‑year ACS of patients who underwent lobectomy, sublobar resection, radiation and observation was 80.3, 72.0, 40.8 and 19.6%, respectively. The 5‑year CCS3 of patients who underwent lobectomy, sublobar resection, radiation and observation was 91.7, 86.4, 77.0 and 58.2%, respectively. CCS3 increased with an increase in survival time and patients who underwent lobectomy had the highest CCS3 estimates and flattest growth, with the smallest survival gap between CCS3 and ACS. The results were similar in the PSM analysis. In conclusion, CS estimates may provide a more accurate survival prediction for patients with stage I NSCLC, and may assist with treatment decisions and surveillance strategies. In addition, the current study provided evidence that suggests lobectomy may be the optimal treatment strategy for stage I NSCLC compared with sublobar resection.

View Figures

View References

1	Owonikoko TK, Ragin CC, Belani CP, Oton AB, Gooding WE, Taioli E and Ramalingam SS: Lung cancer in elderly patients: An analysis of the surveillance, epidemiology, and end results database. J Clin Oncol. 25:5570–5577. 2007. View Article : Google Scholar : PubMed/NCBI
2	Howington JA, Blum MG, Chang AC, Balekian AA and Murthy SC: Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 143 (Suppl 5):e278S–e313S. 2013. View Article : Google Scholar : PubMed/NCBI
3	Dikken JL, Baser RE, Gonen M, Kattan MW, Shah MA, Verheij M, va de Velde CJ, Brennan MF and Coit DG: Conditional probability of survival nomogram for 1-, 2-, and 3-year survivors after an R0 resection for gastric cancer. Ann Surg Oncol. 20:1623–1630. 2013. View Article : Google Scholar : PubMed/NCBI
4	Henson DE and Ries LA: On the estimation of survival. Semin Surg Oncol. 10:2–6. 1994. View Article : Google Scholar : PubMed/NCBI
5	Wang SJ, Fuller CD and Thomas CR Jr: Ethnic disparities in conditional survival of patients with non-small cell lung cancer. J Thorac Oncol. 2:180–190. 2007. View Article : Google Scholar : PubMed/NCBI
6	Skuladottir H and Olsen JH: Conditional survival of patients with the four major histologic subgroups of lung cancer in Denmark. J Clin Oncol. 21:3035–3040. 2003. View Article : Google Scholar : PubMed/NCBI
7	Merrill RM, Henson DE and Barnes M: Conditional survival among patients with carcinoma of the lung. Chest. 116:697–703. 1999. View Article : Google Scholar : PubMed/NCBI
8	Chen F, Cole P and Bina WF: Time trend and geographic patterns of lung adenocarcinoma in the United States, 1973–2002. Cancer Epidemiol Biomarkers Prev. 16:2724–2729. 2007. View Article : Google Scholar : PubMed/NCBI
9	Kim W, Lee HY, Jung SH, Woo MA, Kim HK, Choi YS, Kim J, Zo JI, Shim YM, Han J, et al: Dynamic prognostication using conditional survival analysis for patients with operable lung adenocarcinoma. Oncotarget. 8:32201–32211. 2017.PubMed/NCBI
10	Shirvani SM, Jiang J, Chang JY, Welsh JW, Gomez DR, Swisher S, Buchholz TA and Smith BD: Comparative effectiveness of 5 treatment strategies for early-stage non-small cell lung cancer in the elderly. Int J Radiat Oncol Biol Phys. 84:1060–1070. 2012. View Article : Google Scholar : PubMed/NCBI
11	National Cancer Institue: Surveillance, Epidemiology, and End Results (SEER) Program. http://seer.cancer.govApril. 2017
12	Parzen JS, Bates JE, Milano MT and Dhakal S: Survival after subsequent non-Hodgkin's lymphoma and non-small cell lung cancer in patients with malignant thymoma. J Thorac Dis. 8:3605–3613. 2016. View Article : Google Scholar : PubMed/NCBI
13	Fitz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Max Parkin D and Whelan S: ICD-O-3: International classification of Diseases for Oncology. 3rd. World Health Organization; Geneva: 2000
14	Detterbeck FC, Boffa DJ, Kim AW and Tanoue LT: The eighth edition lung cancer stage classification. Chest. 151:193–203. 2017. View Article : Google Scholar : PubMed/NCBI
15	Austin PC: Statistical criteria for selecting the optimal number of untreated subjects matched to each treated subject when using many-to-one matching on the propensity score. Am J Epidemiol. 172:1092–1097. 2010. View Article : Google Scholar : PubMed/NCBI
16	Merrill RM, Henson DE and Ries LA: Conditional survival estimates in 34,963 patients with invasive carcinoma of the colon. Dis Colon Rectum. 41:1097–1106. 1998. View Article : Google Scholar : PubMed/NCBI
17	Henson DE, Ries LA and Carriaga MT: Conditional survival of 56,268 patients with breast cancer. Cancer. 76:237–242. 1995. View Article : Google Scholar : PubMed/NCBI
18	Nathan H, de Jong MC, Pulitano C, Ribero D, Strub J, Mentha G, Gigot JF, Schulick RD, Choti MA, Aldrighetti L, et al: Conditional survival after surgical resection of colorectal liver metastasis: An international multi-institutional analysis of 949 patients. J Am Coll Surg. 210:755–764. 2010. View Article : Google Scholar : PubMed/NCBI
19	Sun M, Trinh QD and Karakiewicz PI: Conditional survival of patients with metastatic renal-cell carcinoma. Lancet Oncol. 13:e4622012. View Article : Google Scholar : PubMed/NCBI
20	Wang SJ, Emery R, Fuller CD, Kim JS, Sittig DF and Thomas CR: Conditional survival in gastric cancer: A SEER database analysis. Gastric Cancer. 10:153–158. 2007. View Article : Google Scholar : PubMed/NCBI
21	Mayo SC, Nathan H, Cameron JL, Olino K, Edil BH, Herman JM, Hirose K, Schulick RD, Choti MA, Wolfgang CL and Pawlik TM: Conditional survival in patients with pancreatic ductal adenocarcinoma resected with curative intent. Cancer. 118:2674–2681. 2012. View Article : Google Scholar : PubMed/NCBI
22	Kim Y, Ejaz A, Spolverato G, Squires MH, Poultsides G, Fields RC, Bloomston M, Weber SM, Votanopoulos K, Acher AW, et al: Conditional survival after surgical resection of gastric cancer: A multi-institutional analysis of the us gastric cancer collaborative. Ann Surg Onco. 22:557–564. 2015. View Article : Google Scholar
23	Kim Y, Margonis GA, Prescott JD, Tran TB, Postlewait LM, Maithel SK, Wang TS, Glenn JA, Hatzaras I, Shenoy R, et al: Curative Surgical Resection of Adrenocortical Carcinoma: Determining long-term outcome based on conditional disease-free probability. Ann Surg. 265:197–204. 2017. View Article : Google Scholar : PubMed/NCBI
24	Lee JW, Ali B, Yoo HM, Park CH and Song KY: Conditional survival analysis in Korean patients with gastric cancer undergoing curative gastrectomy. BMC Cancer. 15:10052015. View Article : Google Scholar : PubMed/NCBI
25	Merrill RM and Hunter BD: Conditional survival among cancer patients in the United States. Oncologist. 15:873–882. 2010. View Article : Google Scholar : PubMed/NCBI
26	Ito Y, Miyashiro I, Ito H, Hosono S, Chihara D, Nakata-Yamada K, Nakayama M, Matsuzaka M, Hattori M, Sugiyama H, et al: Long-term survival and conditional survival of cancer patients in Japan using population-based cancer registry data. Cancer Sci. 105:1480–1486. 2014. View Article : Google Scholar : PubMed/NCBI
27	Ginsberg RJ and Rubinstein LV: Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg. 60:622–613. 1995. View Article : Google Scholar
28	Martin JT, Durbin EB, Chen L, Gal T, Mahan A, Ferraris V and Zwischenberger J: Nodal upstaging during lung cancer resection is associated with surgical approach. Ann Thorac Surg. 101:238–245. 2016. View Article : Google Scholar : PubMed/NCBI
29	Villamizar N and Swanson SJ: Lobectomy vs. Segmentectomy for NSCLC (T<2 cm). Ann Cardiothorac Surg. 3:160–166. 2014.PubMed/NCBI
30	Kohman LJ, Gu L, Altorki N, Scalzetti E, Veit LJ, Wallen JM and Wang X: Biopsy first: Lessons learned from cancer and leukemia Group B (CALGB) 140503. J Thorac Cardiovasc Sury. 153:1592–1597. 2017. View Article : Google Scholar
31	Suzuki K, Saji SH, Aokage K, Watnabe SI, Okada M, Mizusawa J, Nakajima R, Tsuboi M, Nakamura S, Nakamura K, et al: Comparison of morbidity of pulmonary segmentectomy and lobectomy: Safety results of a randomized trial. J Thorac Cardiovasc Surg. Apr 9–2019.(Epub ahead of print). doi: 10.1016/j.jtcvs.2019.03.090. View Article : Google Scholar
32	Dai C, Shen J, Ren Y, Zhong S, Zheng H, He J, Xie D, Fei K, Liang W, Jiang G, et al: Choice of surgical procedure for patients with non-small-cell lung cancer</=1 cm or>1 to 2 cm among lobectomy, segmentectomy, and wedge resection: A population-based study. J Clin Oncol. 34:3175–3182. 2016. View Article : Google Scholar : PubMed/NCBI
33	Whitson BA, Groth SS, Andrade RS, Maddaus MA, Habermann EB and D'Cunha J: Survival after lobectomy versus segmentectomy for stage I non-small cell lung cancer: A population-based analysis. Ann Thorac Surg. 92:1943–1950. 2011. View Article : Google Scholar : PubMed/NCBI
34	Cao J, Yuan P, Wang Y, Xu J, Yuan X, Wang Z, Lv W and Hu J: Survival rates after lobectomy, segmentectomy and wedge resection for the non-small cell lung cancer. Ann Thorac Surg. 105:1483–1491. 2018. View Article : Google Scholar : PubMed/NCBI
35	Mery CM, Pappas AN, Bueno R, Colson YL, Linden P, Sugarbaker DJ and Jaklitsch MT: Similar long-term survival of elderly patients with non-small cell lung cancer treated with lobectomy or wedge resection within the surveillance, epidemiology, and end results database. Chest. 128:237–245. 2005. View Article : Google Scholar : PubMed/NCBI
36	Noone AM, Lund JL, Mariotto A, Cronin K, McNeel T, Deapen D and Warren JL: Comparison of SEER treatment data with medicare claims. Med Care. 54:e55–e64. 2016. View Article : Google Scholar : PubMed/NCBI
37	Fukui T, Okasaka T, Kawaguchi K, Fukumoto K, Nakamura S, Hakiri S, Ozeki N and Yokoi K: Conditional survival after surgical intervention in patients with non-small cell lung cancer. Ann Thorac Surg. 101:1877–1882. 2016. View Article : Google Scholar : PubMed/NCBI
38	Bosco JL, Silliman RA, Thwin SS, Geiger AM, Buist DS, Prout MN, Yood MU, Haque R, Wei F and Lash TL: A most stubborn bias: No adjustment method fully resolves confounding by indication in observational studies. J Clin Epidemiol. 63:64–74. 2010. View Article : Google Scholar : PubMed/NCBI